Targeted Oncology |
New Horizons in Treatment for Patients With Polycythemia Vera
Targeted Oncology “Polycythemia vera is a disease that is evolving quite a bit—it really is not the 'P vera' of 1995, in which it was just a question of phlebotomy, aspirin, and hydroxyurea,” Ruben A. Mesa, MD, deputy director of the Mayo Clinic Cancer Center in ... |
from phlebotomy - Google News http://bit.ly/20wLS0x
No comments:
Post a Comment